Revenue
$1.5B
▼ 5.2% YoY
Net Income
$241.7M
▼ 34.2% YoY
EPS
$1.43
▼ 34.1% YoY
Cash
$388.6M
▲ 33.5% YoY
FY 2025 · As of 2025-12-31
Last 90 days
| Insider | Type | Date | Shares | Price | Value | |
|---|---|---|---|---|---|---|
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Vest | May 1, 2026 | 5.0K | $19.34 | $97K | Form 4 ↗ |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sell | May 1, 2026 | 9.0K | $33.40 | $301K | Form 4 ↗ |
Lurker Nancy Director | Vest | Apr 11, 2026 | 3.8K | - | - | Form 4 ↗ |
Lurker Nancy Director | Sell tax | Apr 11, 2026 | 901 | $33.36 | $30K | Form 4 ↗ |
Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sell | Apr 6, 2026 | 2.0K | $34.57 | $70K | Form 4 ↗ |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Vest | Apr 1, 2026 | 5.0K | $19.34 | $97K | Form 4 ↗ |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sell | Apr 1, 2026 | 9.0K | $35.51 | $320K | Form 4 ↗ |
Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sell | Mar 3, 2026 | 2.0K | $29.76 | $61K | Form 4 ↗ |
Parisi Samuel Joseph VP, Finance (Interim PAO) | Sell | Mar 2, 2026 | 6.9K | $29.29 | $202K | Form 4 ↗ |
Nichols Christian Todd SVP, Chief Commercial Officer | Sell | Mar 2, 2026 | 6.0K | $30.00 | $180K | Form 4 ↗ |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Vest | Mar 2, 2026 | 5.0K | $19.34 | $97K | Form 4 ↗ |
Hopkinson Craig C. EVP R&D, Chief Medical Officer | Sell | Mar 2, 2026 | 9.0K | $29.72 | $267K | Form 4 ↗ |
Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Sell | Mar 2, 2026 | 2.0K | $29.29 | $60K | Form 4 ↗ |
Parisi Samuel Joseph VP, Finance (Interim PAO) | Vest | Feb 26, 2026 | 2.7K | - | - | Form 4 ↗ |
Parisi Samuel Joseph VP, Finance (Interim PAO) | Sell tax | Feb 26, 2026 | 808 | $30.73 | $25K | Form 4 ↗ |